Notably, the metabolic phenotype found in RICTOR-knockout keratinocytes, consisting of a switch from a glycolytic- to an OXPHOS-based energetic metabolism fueled by glutamine consumption, is reminiscent of that of targeted therapy-resistant melanoma cells. This evidence concerns the gene RICTOR and melanoma.